AngioWaveNet vs Eko Low Ejection Fraction Tool (ELEFT)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by AngioWave
VS

AI Verdict

AngioWaveNet is designed for enhancing fluoroscopic angiograms to improve vessel visualization during cardiac catheterization procedures. In contrast, the Eko Low Ejection Fraction Tool (ELEFT) is an AI algorithm that integrates with digital stethoscopes to aid in the early detection of low ejection fraction during routine physical exams. While both leverage AI in cardiology, AngioWaveNet focuses on image clarity for interventional procedures, whereas ELEFT targets non-invasive diagnostic screening for heart failure risk.

Choose AngioWaveNet if…

Choose AngioWaveNet if your cardiac catheterization lab requires enhanced real-time visualization of blood vessels during interventional procedures. This tool is ideal for improving the clarity and detail of fluoroscopic angiograms, aiding interventional cardiologists and radiologists in complex cases by integrating seamlessly with existing cath lab workflows.

View AngioWaveNet →

Choose Eko Low Ejection Fraction Tool (ELEFT) if…

Choose Eko Low Ejection Fraction Tool (ELEFT) if you need a non-invasive, early screening tool for heart failure risk during routine physical examinations. This AI-powered solution, integrated with Eko digital stethoscopes, is best suited for primary care physicians or general cardiologists seeking to quickly identify patients with potential low ejection fraction for proactive management.

View Eko Low Ejection Fraction Tool (ELEFT) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AngioWaveNet Eko Low Ejection Fraction Tool (ELEFT)
Pricing Pricing options include annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs. custom packages are available. Unknown
Deployment Cloud-based or on-premise/servers Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AngioWaveNet

AngioWaveNet integrates seamlessly with existing Cath lab workflows and is vendor-agnostic, functioning as a DICOM endpoint for any fluoroscopic angiography system. It requires minimal training due to its intuitive design and processes images almost immediately, ensuring smooth workflow integration.

Clinical Value

Eko Low Ejection Fraction Tool (ELEFT)

While AngioWaveNet enhances critical imaging for interventional procedures, Eko Low Ejection Fraction Tool (ELEFT) offers significant value in the early, non-invasive detection of low ejection fraction, a key indicator of heart failure. This early identification during routine physical exams has the potential for broader population health impact through timely intervention and improved patient outcomes.

Pricing & Value

AngioWaveNet

AngioWaveNet provides more transparent pricing options, including annual software licensing or subscription-based access, which can be tailored to cath lab volume and hospital needs. In contrast, ELEFT requires direct contact for pricing, offering less immediate clarity on its cost structure.

Enterprise Readiness

AngioWaveNet

Both tools are FDA-cleared and HIPAA compliant, demonstrating foundational enterprise readiness. However, AngioWaveNet offers both cloud-based and on-premise deployment options, providing greater flexibility for diverse enterprise IT infrastructures and data governance requirements compared to ELEFT's cloud-based integration.

Innovation

Eko Low Ejection Fraction Tool (ELEFT)

AngioWaveNet innovates by applying AI to enhance a mature imaging technology, improving vessel visualization. ELEFT, however, demonstrates a more disruptive innovation by integrating AI into a common diagnostic tool (digital stethoscope) for rapid, non-invasive early detection of a critical and widespread condition like heart failure during routine physical exams.

Support & Docs

Eko Low Ejection Fraction Tool (ELEFT)

Eko Health (Tool B) offers a more comprehensive and publicly detailed support infrastructure, including a dedicated Help Center, live Q&A sessions, 1:1 phone calls, email support, and a system to create support tickets. While AngioWaveNet (Tool A) provides onboarding support and resources, Eko's offerings appear more extensive and readily accessible for ongoing support and documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AngioWaveNet Eko Low Ejection Fraction Tool (ELEFT)
Tool Name AngioWaveNet Eko Low Ejection Fraction Tool (ELEFT)
Company Angiowave Imaging Eko Health
Primary Function/Purpose Enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories. Aids clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams.
Integration Integrates with existing Cath lab workflows; Compatible with any fluoroscopic angiography system (vendor-agnostic); Functions as a DICOM endpoint. Integrates with FDA-cleared Eko digital stethoscopes.
Key Technology/Method AI-powered Spatiotemporal Enhancement Processing (STEPu2122); Post-processing AI for angiographic images. AI algorithm; Analyzes ECG and heart sound recordings; Provides results in approximately 15 seconds.
Target Specialties Cardiology, Interventional Radiology, Vascular Surgery Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring AngioWaveNet and Eko Low Ejection Fraction Tool (ELEFT).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AngioWaveNet is FDA-cleared AI software designed to enhance fluoroscopic angiograms, improving vessel visualization in cardiac catheterization laboratories. Eko Low Ejection Fraction Tool (ELEFT) is an FDA-cleared AI algorithm that aids clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams.
AngioWaveNet integrates with existing Cath lab workflows and is compatible with any fluoroscopic angiography system as a DICOM endpoint. ELEFT integrates with FDA-cleared Eko digital stethoscopes to analyze ECG and heart sound recordings, providing results in approximately 15 seconds.
AngioWaveNet is primarily intended for Cardiology, Interventional Radiology, and Vascular Surgery. ELEFT is designed for use in Cardiology, Family Medicine, and Internal Medicine.

Backers

Who funded each tool's parent company.

Eko Low Ejection Fraction Tool (ELEFT)

AI Tool Finder
AI-powered search. Results may not be comprehensive.